Markets & Stocks

Stock quotes, market indicators and the latest market news.

Market Summary Market News Stock Quotes Market Movers
Recent Quotes
My Watchlist
Indicators
Local Stocks
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kairos Pharma, Ltd. Common Stock (NY:KAPA)

1.620 +0.060 (+3.84%)
Delayed Quote Updated: 9:38 AM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,401
Open 1.610
Bid (Size) 1.520 (600)
Ask (Size) 1.580 (300)
Prev. Close 1.560
Today's Range 1.565 - 1.620
52wk Range 1.470 - 9.590
Shares Outstanding 20,821,353
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
NetworkNewsBreaks – Kairos Pharma Ltd. (NYSE American: KAPA) to Present KROS-101 Research at Discovery on Target Conference
Via Investor Brand Network
News headline image
Kairos Pharma to Present and Moderate at Discovery on Target Conference in Boston, MA
From Kairos Pharma, Ltd
Via Business Wire

Performance

YTD
-68.3%
-68.3%
1 Month
-1.8%
-1.8%
3 Month
-37.5%
-37.5%
6 Month
-60.2%
-60.2%
1 Year
-79.5%
-79.5%

More News

Read More
InvestorNewsBreaks – Kairos Pharma Ltd. (NYSE American: KAPA) CEO to Present at H.C. Wainwright 28th Annual Global Investment Conference
Via Investor Brand Network
News headline image
Kairos Pharma to Present at the H.C. Wainwright 28th Annual Global Investment Conference
From Kairos Pharma, Ltd
Via Business Wire
Top movers in Monday's session ↗
Via Chartmill
Which stocks are experiencing notable movement on Monday? ↗
Via Chartmill
Monday's session: gap up and gap down stocks ↗
Via Chartmill
News headline image
Kairos Pharma Announces 1-for-7 Reverse Stock Split
From Kairos Pharma, Ltd
Via Business Wire
What's going on in today's after hours session ↗
Via Chartmill
These stocks have an unusual volume in today's session ↗
Via Chartmill
TinyGemsBreaks – Kairos Pharma Ltd. (NYSE American: KAPA) Collaborates With Bayer to Evaluate Combination Therapy for Advanced Prostate Cancer
Via Investor Brand Network
News headline image
Kairos Pharma Announces Strategic Collaboration with Bayer to Enhance XOFIGO Activity in Metastatic Prostate Cancer
From Kairos Pharma, Ltd
Via Business Wire
The trading volume of these stocks is deviating from the norm in today's session. ↗
Via Chartmill
What's going on in today's pre-market session ↗
Via Chartmill
In today's session, these stocks are experiencing unusual volume. ↗
Via Chartmill
BioMedNewsBreaks — Kairos Pharma Ltd. (NYSE American: KAPA) Reports Favorable Interim Phase 1 Safety Data for ENV-105 in EGFR-Mutated Lung Cancer
Via Investor Brand Network
News headline image
Kairos Pharma Reports Breakthrough Interim Safety Data in Phase 1 Trial of ENV-105 in EGFR-Mutated Lung Cancer Patients — Targeting a $10 Billion Drug Resistance Market
From Kairos Pharma, Ltd
Via Business Wire
TinyGemsBreaks – Kairos Pharma Ltd. (NYSE American: KAPA) Highlights Pipeline Expansion and Clinical Milestones in Mid-Year Shareholder Update
Via Investor Brand Network
News headline image
Kairos Pharma Recaps Important Acquisitions and Details Plans for the Balance of 2026 in Letter to Shareholders
From Kairos Pharma, Ltd
Via Business Wire
BioMedNewsBreaks – Kairos Pharma Ltd. (NYSE American: KAPA) Receives 2026 Healthcare Innovation Award for Drug Resistance Research
Via Investor Brand Network
News headline image
Kairos Pharma Receives GHP Magazine’s Healthcare & Pharmaceutical Award
From Kairos Pharma, Ltd
Via Business Wire
InvestorNewsBreaks – Kairos Pharma Ltd. (NYSE American: KAPA) to Present at LD Micro Invitational XVI
Via Investor Brand Network
TinyGemsBreaks – Kairos Pharma Ltd. (NYSE American: KAPA) Sets Virtual Annual Meeting, Discloses Going Concern Notice
Via Investor Brand Network
Topics Regulatory Compliance
News headline image
Kairos Pharma, Ltd. Sets Annual Meeting of Shareholder Date and Provides Update on Its Annual Filings
From Kairos Pharma, Ltd
Via Business Wire
InvestorNewsBreaks – Kairos Pharma Ltd. (NYSE American: KAPA) Earns 2026 Pinnacle Award for Biotech Innovation in Cancer Drug Resistance
Via Investor Brand Network

Frequently Asked Questions

Is Kairos Pharma, Ltd. Common Stock publicly traded?
Yes, Kairos Pharma, Ltd. Common Stock is publicly traded.
What exchange does Kairos Pharma, Ltd. Common Stock trade on?
Kairos Pharma, Ltd. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Kairos Pharma, Ltd. Common Stock?
The ticker symbol for Kairos Pharma, Ltd. Common Stock is KAPA on the New York Stock Exchange
What is the current price of Kairos Pharma, Ltd. Common Stock?
The current price of Kairos Pharma, Ltd. Common Stock is 1.620
When was Kairos Pharma, Ltd. Common Stock last traded?
The last trade of Kairos Pharma, Ltd. Common Stock was at 10/02/26 09:38 AM ET
What is the market capitalization of Kairos Pharma, Ltd. Common Stock?
The market capitalization of Kairos Pharma, Ltd. Common Stock is 33.73M
How many shares of Kairos Pharma, Ltd. Common Stock are outstanding?
Kairos Pharma, Ltd. Common Stock has 34M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.